Skip to main content

and
  1. Article

    Open Access

    Polygenic scores for cardiovascular risk factors improve estimation of clinical outcomes in CCB treatment compared to pharmacogenetic variants alone

    Pharmacogenetic variants are associated with clinical outcomes during Calcium Channel Blocker (CCB) treatment, yet whether the effects are modified by genetically predicted clinical risk factors is unknown. We...

    Deniz Türkmen, Jack Bowden, Jane A. H. Masoli, João Delgado in The Pharmacogenomics Journal (2024)

  2. Article

    Open Access

    Effects of physical activity and sedentary time on depression, anxiety and well-being: a bidirectional Mendelian randomisation study

    Mental health conditions represent one of the major groups of non-transmissible diseases. Physical activity (PA) and sedentary time (ST) have been shown to affect mental health outcomes in opposite directions....

    Francesco Casanova, Jessica O’Loughlin, Vasilis Karageorgiou in BMC Medicine (2023)

  3. Article

    Open Access

    Body mass index and inflammation in depression and treatment-resistant depression: a Mendelian randomisation study

    Major depressive disorder (MDD) has a significant impact on global burden of disease. Complications in clinical management can occur when response to pharmacological modalities is considered inadequate and sym...

    Vasilios Karageorgiou, Francesco Casanova, Jessica O’Loughlin, Harry Green in BMC Medicine (2023)

  4. Article

    Open Access

    Mendelian randomisation study of body composition and depression in people of East Asian ancestry highlights potential setting-specific causality

    Extensive evidence links higher body mass index (BMI) to higher odds of depression in people of European ancestry. However, our understanding of the relationship across different settings and ancestries is lim...

    Jessica O’Loughlin, Francesco Casanova, Zammy Fairhurst-Hunter in BMC Medicine (2023)

  5. Article

    Open Access

    Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer

    Dietary factors are assumed to play an important role in cancer risk, apparent in consensus recommendations for cancer prevention that promote nutritional changes. However, the evidence in this field has been ...

    Kaitlin H. Wade, James Yarmolinsky, Edward Giovannucci in Cancer Causes & Control (2022)

  6. Article

    Open Access

    Realising the full potential of MR-PHeWAS in cancer

    MR-PHeWAS is a powerful new design for discovering causal mechanisms between a disease and its many candidate risk factors in a hypothesis-free manner. This technique has great potential in the field of cancer...

    Jack Bowden in British Journal of Cancer (2021)

  7. No Access

    Article

    Biological and clinical insights from genetics of insomnia symptoms

    Insomnia is a common disorder linked with adverse long-term medical and psychiatric outcomes. The underlying pathophysiological processes and causal relationships of insomnia with disease are poorly understood...

    Jacqueline M. Lane, Samuel E. Jones, Hassan S. Dashti, Andrew R. Wood in Nature Genetics (2019)

  8. No Access

    Article

    Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits

    Richa Saxena and colleagues report genome-wide association analyses of sleep disturbance traits in the UK Biobank cohort. They discover loci associated with insomnia symptoms and excessive daytime sleepiness a...

    Jacqueline M Lane, **g**g Liang, Irma Vlasac, Simon G Anderson in Nature Genetics (2017)

  9. Article

    Open Access

    Correcting for selection bias in two-stage trials with multiple correlated outcomes: application to seamless phase ii/iii clinical trials

    David Robertson, A Toby Prevost, Jack Bowden in Trials (2015)

  10. Article

    Open Access

    Patient drift and response-adaptive randomisation: impact and solutions

    Sofia S Villar, James Wason, Jack Bowden in Trials (2015)

  11. Article

    Open Access

    Type I error control in biomarker-stratified clinical trials

    Deepak Parashar, Jack Bowden, Colin Starr, Lorenz Wernisch, Adrian Mander in Trials (2015)

  12. Article

    Open Access

    Revisiting the multi-armed bandit model for the optimal design of clinical trials: benefits and drawbacks

    Sofia S Villar, Jack Bowden, James Wason in Trials (2013)

  13. Article

    Open Access

    Impact of lack-of-benefit stop** rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome

    Babak Choodari-Oskooei, Max KB Parmar, Patrick Royston, Jack Bowden in Trials (2013)

  14. Article

    Open Access

    Adaptive enrichment in biomarker-stratified clinical trial design

    Deepak Parashar, Jack Bowden, Colin Starr, Lorenz Wernisch, Adrian Mander in Trials (2013)

  15. Article

    Open Access

    Impact of lack-of-benefit stop** rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome

    In 2011, Royston et al. described technical details of a two-arm, multi-stage (TAMS) design. The design enables a trial to be stopped part-way through recruitment if the accumulating data suggests a lack of benef...

    Babak Choodari-Oskooei, Mahesh KB Parmar, Patrick Royston, Jack Bowden in Trials (2013)

  16. Article

    Open Access

    Designing a preliminary adaptive study to inform a biomarker trial in Psoriasis

    Andrew T Prevost, Jack Bowden in Trials (2011)